Amazon's new GLP-1 push comes days after Walmart unveiled its own platform — as big players race to capture demand for the drugs.
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Aïda Amer/Axios
Amazon's One Medical is rolling out a national GLP-1 program as demand for weight-loss drugs surges, the company announced Tuesday.
Why it matters: The boom in drugs like Ozempic and Wegovy is reshaping obesity care — but also exposing gaps in how patients are treated.
Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1…
Walmart is expanding beyond prescriptions in the GLP-1 boom, with a platform that connects virtual care, nutrition and pharmacy.
Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for…
The announcement expands the offerings under the company's weight management program as its membership grows to more than 800,000.
Amazon Pharmacy began delivering GLP-1 medications in 2021, but does not stock injectable versions of the drugs in kiosks because…
The connection between weight loss drugs, jet fuel and the software sell-off explained.
